Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Cannabis
If We Got Boehner, We Can Get Anyone: Washington's Growing Role in Legal Weed
Cannabis isn't a red and blue issue in Washington. Here's how the political landscape is changing as marijuana prohibition becomes 'politically untenable.'
U.S. Markets 'Definitively' Missing Out on Capital by Barring Cannabis Companies
The U.S. markets are missing out on the rise of the cannabis industry, according to several experts TheStreet talked with on the topic.
Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.?
More research is needed, but medical experts agree that cannabis plants have immense potential to slow opioid drug overdoses, which claim 115 lives every day in the U.S.
Weed Sales in Canada Could Top $7 Billion After Full Legalization This Summer
Nearly two-thirds of cannabis consumers will transition to legal channels and subsequently pay more, according to a new study from Deloitte.
Cannabis Company Green Thumb Industries Heads to Canada to Go Public
Chicago-based Green Thumb Industries is the latest cannabis company to abandon hope of a U.S. IPO in favor of a reverse takeover in Canada and access to growth capital.
5 Cannabis Products You Never Knew You Needed
From dog treats to face wash, these are the next big thing in cannabis.
Weed Companies Need to 'End Prohibition' Before They Can List Shares in the U.S.
MedMen is now selling shares on the Canadian Securities Exchange. Here's why it still isn't possible for the $1.65 billion company to list in its home country.
The Largest U.S. Cannabis Company Finds a Home on a Canadian Exchange
MedMen is now selling shares on the Canadian Securities Exchange. Here's why it still isn't possible for the $1.65 billion company to list in its home country.
Why Kiss Legend Gene Simmons Is Betting on Cannabis
Rock legend Gene Simmons is all in on cannabis despite being notoriously anti drugs and alcohol.
Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz
Legal-weed company Canopy Growth lists on New York Stock Exchange, but falls some 6% in first session.